Nov 14, 2022 | Company News, Genius Engage, Genius Suite
Genius vENGAGE: The Remote Verbal Consent for a Patient-Centric Clinical Trial Exom Group, a Clinscience company, is proud to announce the release of the first patient-centric “reliable & compliant” remote verbal consent for clinical trials (Genius vENGAGE). The...
Dec 6, 2017 | Articles, Clinical Trial News, Genius Engage, Genius Suite, Luigi Visani, Meeting & Conference
On November 14th, Luigi Visani, CEO of Exom Group, has been among the speakers of the seminar organized by the Polish Association of GCPs Professionals entitled “The e-solutions in medicine, such as eHR and eICF, will revolutionize clinical research ? “ and made a...
May 11, 2017 | Genius Engage, Genius Suite
The first electronic Informed Consent fully combined with the eTMF Exom Group, the Human Digital CRO, has launched Genius ENGAGE™, the industry’s first ever electronic Informed Consent solution whose digital workflow is fully combined with the eTMF, and integrated...
Nov 16, 2016 | Articles, Clinical Trial News, Genius Engage, Genius Suite
Transform the Informed Consent process in clinical trials Exom Group introduced Genius ENGAGE™ the first electronic Informed Consent (eIC) application combined with the cloud platform Genius eTMF™. When the site specific version of the ICF has been approved and filed...
